NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/12/2024
Back to search
Official data from USPTO
AP ASKPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
03/12/2024
Classification
Registered
Trademark type
Combined
Nice classes
5, 42
Filing date
02/21/2023
Registration date
03/12/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/12/2024
Last transaction
03/12/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/23/2023
First use in commerce
03/23/2023
Drawing code
3
Owner type
03
Owner location
Princeton, NJ
Examiner
POLLACK, ALISON
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of two stylized green letters AP with gold and dark red edge. On top of the letter A, there are three green leaves with gold and dark red edge. Below the letters AP, there is one green word "AskPharma" with gold and dark red edge.
Holders and representatives
Holders
AskPharma, Inc.
Representatives
ZIXUAN ZHOU
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cardiovascular pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical products for the treatment of cancer
Class 42
Pharmaceutical research services
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/26/2023
PUBO
PUBLISHED FOR OPPOSITION
12/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/06/2023
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
11/21/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/20/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
11/20/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/20/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
11/20/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/20/2023
IUAA
USE AMENDMENT ACCEPTED
11/20/2023
DOCK
ASSIGNED TO EXAMINER
11/20/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
09/02/2023
IUAF
USE AMENDMENT FILED
09/02/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
09/01/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2023
NWAP
NEW APPLICATION ENTERED
02/24/2023
Continuous trademark protection
Get notified about every new filing that threatens AP ASKPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.